MNMD
Mind Medicine (MindMed) Inc.
NASDAQ · Healthcare · Biotechnology · CA
$20.69
+0.44%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -86.1%
- EBIT
- -60.0%
- EPS
- -13.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- -68.4%
- EBIT
- -60.0%
- Net income
- -69.1%
- EPS
- -33.8%
- Free cash flow
- -66.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025